A new series of complex conjugated imine 10a-r analogs of anticancer drug Imatinib were synthesized in moderate to good yields, under ecofriendly conditions. Some of these molecules containing fluorine atoms and privileged scaffolds such as, pyridine and pyrrole. These molecules could have potential applications in medicinal chemistry
Introduction
The synthesis of library of complex nitrogen heterocycles under eco-friendly conditions, good yields and with a wide variety of biological activities presents a challenge to synthetic chemists [1] . One way to achieve this, is by employing the combinatorial chemistry approach that allows synthesize compounds via rapid and efficient methodologies, with a variety of substituents simple and complex as heterocyclic scaffolds of interest in medicinal chemistry [2] . Condensation of a primary amine with an aldehyde or ketone to obtain imines compounds is an example of such reactions and was first reported by Hugo Schiff in 1864. Schiff bases are of great importance in medicinal chemistry, considered as "privileged ligands ", due their derivatives or analogues have been shown to exhibit a plethora of biological activities, including anti-cancer, antiviral, antibacterial, antifungal, antioxidant, anticonvulsant, anti-inflammatory, antitubercular, antidepressant and antimalarial properties [3] [4] [5] . The biological activity of these molecules is mainly due to the hydrogen bond formation between the target and the lone pair of electrons in a sp 2 hybridized orbital of nitrogen atom of the imine functional group (-C=N-) [6] .
On the other hand, phenylaminopyrimidines (PAP, blue color figure 1) are regarded as privileged scaffolds in medicinal chemistry, resulting of their well documented anticancer properties. [7] [8] [9] . Imatinib 1, is an anticancer drug approved by FDA in 2001 for the treatment of chronic myeloid leukemia (CML) and in 2003 for treatment of gastrointestinal stromal tumor (GIST). The interest in the synthesis of new derivatives or analogues of Imatinib is due to the resistance showed of some patients under Imatinib treatment (examples are shown in Figure 1 ). [10, 11] . The condensation of aldehydes and amines for synthesized imines is well known methodology. However, the synthesis of Schiff bases from complex anilines and aromatic (fluorinated) or nitrogenated heteroaromatic (five and six members) aldehydes is practically unexplored [12] [13] [14] [15] [16] .
Herein we report the synthesis of a new series of complex conjugated imines containing the fragment PAP present in the anticancer drug Imatinib (Imines-PAP) using the conditions reported by Mohana in 2010 [17, 18] . Besides the conjugated imines-PAP reported here contain nitrogenated heteroaromatic scaffolds of interest in medicinal chemistry such as, pyridine or pyrrole. The aldehydes used contain as substituents fluorine atoms and hydroxyl groups.
Materials and Methods

Experimental Section
All chemical reagents and solvents were purchased from Sigma-Aldrich Co. without further purification. Thin-layer chromatography (TLC) was performed with silica gel plates from Merck (silica gel 60 F254), that were visualized by exposure to ultraviolet light and by using as eluent a mixture of heptane and ethyl acetate. NMR spectra were recorded on Bruker spectrometer Avance 400 MHz and Fourier 300 MHz using TMS as an internal reference. Chemical Shift () are reported in ppm, and J values are given in Hertz, and deuterated DMSO-d6 was used as solvent. Highresolution mass spectrometry (HRMS) was performed using a Micro TOF-II spectrometer and the samples were ionized by electrospray ionization on positive mode (ESI + ). FT-IR spectra were recorded on a Perkin Elmer 100 FT-IR spectrometer by ATR method using neat compounds. The wavelengths are reported in reciprocal centimeters (v/cm -1 ). Melting points were determined on a Mettler Toledo apparatus.
Preparation of amino compound (amino-PAP)
The component amino-PAP was synthesized via the methodology reported by Zimmerman. (Scheme 1) [19] . Scheme 1. Synthesis of amino-PAP.
General procedure for complex conjugated imines-PAP 10a-r
The complex conjugated imines-PAP were synthesized according to the reported methodology [17, 18] : To Ethanol (0.4M) was added to a mixture of amino-PAP 8 (0.7 mmol, 1 eq) and aldehyde (0.7 mmol, 1eq). The reaction mixture was stirred at room temperature until reaction complete by solid formation and then the suspension was filtered and washed with 3 mL of Ethanol and dried under vacuum to afford the imine-PAP 10a-r. N-(2-methyl-5-((pyridin-3-ylmethylene)amino)phenyl)-4-(pyridin-3-yl) Firstly, a series of fluorinated conjugated imines-PAP 10a-f were synthesized. The synthesis of target-molecule containing fluorine atoms is a common strategy in the drug discovery process, as it can improve their binding affinity, metabolic stability, lipophilicity and basicity [20] [21] [22] . Besides approximately 30% of new approved drugs contain at least one fluorine atom [20] . Fluorinated imines-PAP 10a-f possibly have activity as inhibitors to pan-PIM kinase as the fluorinated analogues reported by Nishiguchi et al. [23] . Moreover, the synthesis of at least two biologically active molecules in the same molecule to design a new hybrid compounds is a powerful strategy on drug design and analogues drugs. This strategy is known as molecular hybridization [24, 25] . Accordingly, the novel hybrid imines containing heterocycles considered as privileged scaffolds such as pyrrol (pyrrol-PAP 10g) [26] , and pyridine [27] (Pyridine-PAP 10i and 10j) were synthesized. These complex conjugated imines-PAP, therefore, represent a contribution to the synthesis of Schiff bases containing nitrogenated heterocycles.
(E)-N-(5-((2-fluorobenzylidene)amino)-2-methylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-N-(5-((2,3-difluorobenzylidene)amino)-2-methylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-N-(5-((2,4-difluorobenzylidene)amino)-2-methylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-N-(5-((2,5-difluorobenzylidene)amino)-2-methylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-N-(2-methyl-5-(((perfluorophenyl)methylene)amino)phenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-N-(5-(((1H-pyrrol-2-yl)methylene)amino)-2-methylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-N-(2-methyl-5-((4-(pyridin-2-yl)benzylidene)amino)phenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
(E)-
(E)-4-(((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)imino)methyl)phenol
(E)-4-(((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)imino)methyl)benzene-1,2-diol
Conclusions
Complex conjugated imines-PAP analogs of Imatinib 10a-r were obtained under eco-friendly conditions in moderate to good yields with good substrate scope. These new analogues imines-PAP containing nitrogenated heterocycles and fluorine atoms, can serve as promising anticancer compounds.
